Vaccine World Summit India 2014(Mar 4-6, Hyderabad, India)

Vaccine World Summit India 2014

Date: 4 - 6 March 2014

Venue: Hyderabad, India

 

Vaccine World Summit is the most sought after vaccine industrial gathering for India and rest of the developing country manufacturers. Led by demand from the industry and the success of last three years' conferences, Vaccine world Summit 2014 promises to be an even greater experience!

 

Vaccine World Summit India will be THE DEFINITIVE meeting place for vaccine industry players to come together to establish and renew partnerships to help develop new products, acquire new technologies, and establish new relationships.

 

5 Reasons to Attend:

• Network with high level decision makers and key opinion leaders in India and the rest of the world
• Discuss business strategies and the recent market trends to ensure sustainable growth
• Understand the latest policy and regulatory changes and challenges to increase the speed to market
• Exchange ideas on new technologies and discover innovative vaccine development through interesting case studies and showcases
• Learn more about novel trends  in improving manufacturing and operational excellence to conform to international standards

Highlights of the 2014 event

• 3 days of intense knowledge sharing and networking opportunities
• 40+ world class speakers
• 15 hours of networking
• 200+ attendees from vaccine manufacturers, vaccine biotechs, investors, regulators, CROs and technology companies
• A targeted technology exhibition and technical seminars showcasing the latest technology to fast track vaccine R&D and manufacturing

Featured speakers include:

      • Dr Jaap Goudsmit, Director, Crucell Vaccine Institue, Netherlands

      • Kim C. Bush, Director, Life Sciences Partnerships Global Health Program, Office of the President, USA

      • Dr. Krishna Ella, Chairman & Managing Director, Bharat Biotech International Limited, India

      • Dr John Donnelly, Director of the Polio Vaccine Development Project, PATH, U.S.A

      • Mahima Datla, Managing Director, Biological E. Limited, India

      • Dr Suresh Jadhav, Executive Director, Serum Institute of India Ltd, India

      • Dr. Josemund Menezes, Regional Director, Clinical Development Sanofi Pasteur , Asia Pacific

      • Dr. Vadim Tsvetnitsky, Scientific Director, Influenza Vaccine Project, PATH, USA

      • Raj Mehta, Head SEA Cluster, Novartis Vaccines International Region

      • Dr Ananda Amarasinghe, Adviser, WHO Global Advisory Committee on Vaccine Safety (GACVS); Senior consultant Epidemiologist, Ministry of Health, Sri Lanka

      • Dr. Harish Iyer, CEO, Shantha Biotechnics , India

      • Prof. V. S. Chauhan, Group Leader, ICGEB; Governing Body, MVDP, India and many more!

 

Contact Jen Cheng for more details!
T: +6493 1871
E: jen.cheng@Imapac.com

 

Click here to download the conference brochure!